Shanghai Henlius Biotech, Inc. (HKG:2696)
Hong Kong
· Delayed Price · Currency is HKD 69.40
+3.45 (5.23%)
Mar 10, 2026, 1:44 PM HKT
Shanghai Henlius Biotech Market Cap
Shanghai Henlius Biotech has a market cap or net worth of 35.84 billion as of March 9, 2026. Its market cap has increased by 213.30% in one year.
Market Cap
35.84B
Enterprise Value
38.80B
Revenue
6.35B
Ranking
n/a
PE Ratio
39.68
Stock Price
69.40
Market Cap Chart
Since September 25, 2019, Shanghai Henlius Biotech's market cap has increased from 26.66B to 35.84B, an increase of 34.45%. That is a compound annual growth rate of 4.69%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TransThera Sciences (Nanjing) | 36.71B |
| Biocytogen Pharmaceuticals (Beijing) | 35.60B |
| Shanghai Junshi Biosciences | 32.13B |
| Duality Biotherapeutics | 28.45B |
| 3SBio | 53.95B |
| Genscript Biotech | 24.99B |
| InnoCare Pharma | 23.79B |
| PegBio | 23.50B |